Literature DB >> 10727978

Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours.

A P Dei Tos1, C Doglioni, S Piccinin, R Sciot, A Furlanetto, M Boiocchi, P Dal Cin, R Maestro, C D Fletcher, G Tallini.   

Abstract

Atypical lipomatous tumours (ALTs) represent a distinctive subset of mesenchymal neoplasms featuring mature adipocytic differentiation. Most ALTs are characterized cytogenetically by the presence of supernumerary ring and/or long marker chromosomes derived from the chromosomal region 12q13-15. The 12q13-15 chromosome region contains several genes which may play an important role in human tumorigenesis. A series of ALTs was analysed by investigating the MDM2, CDK4, and HMGI-C genes and their proteins. The study was extended to a series of ordinary lipomas, to determine whether the immunohistochemical investigation of these gene products might play any diagnostic role. Cytogenetic analysis revealed the presence of various cytogenetic aberrations involving the 12q13-15 region in 11/18 (61%) lipomas and of ring chromosomes in all ALTs. Overexpression of mdm2 protein was observed in 6/12 (50%) atypical lipomatous tumours. All lipomas were mdm2-negative. cdk4 overexpression was present in 100% of ALTs. Weak cdk4 immunopositivity was detected in 2/18 (11%) ordinary lipomas in a minority of cells. HMGI-C immunopositivity was observed in 10/12 (83%) ALTs. Positive immunoreactivity was also observed in 8/18 (44%) lipomas. Southern blot analysis revealed amplification of the CDK4 and MDM2 genes in 3/5 ALTs analysed. HMGI-C was amplified in 3/5 cases and was deleted in one case. Mutation analysis of the CDK4 gene did not demonstrate any mutation. These data support the hypothesis that ordinary lipomas may form a molecular genetic and morphological continuum with ALT. At one end of the spectrum are lipomas characterized by 12q13-15 rearrangements and HMGI-C activation and at the other end are ALTs with ring chromosomes, 12q13-15 amplification with overrepresentation of the HMGI-C, CDK4 or MDM2 genes, and aberrant cdk4, mdm2, and HMGI-C protein expression. These findings not only provide insights into the molecular pathogenesis of lipomatous tumours, but also indicate that the immunohistochemical analysis of mdm2 and cdk4 may help to increase diagnostic accuracy. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10727978     DOI: 10.1002/(SICI)1096-9896(200004)190:5<531::AID-PATH579>3.0.CO;2-W

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  73 in total

1.  Chondroid lipoma is characterized by t(11;16)(q13;p12-13).

Authors:  Florence Ballaux; Maria Debiec-Rychter; Ivo De Wever; Raf Sciot
Journal:  Virchows Arch       Date:  2004-01-14       Impact factor: 4.064

2.  Well-differentiated liposarcoma of the oesophagus: clinicopathological, immunohistochemical and array CGH analysis.

Authors:  Jae Kyung Myung; Ji Bong Jeong; Daehee Han; Chi Sung Song; Hyeon Jong Moon; Young A Kim; Ji Eun Kim; Sun-Ju Byun; Woo Ho Kim; Mee Soo Chang
Journal:  Pathol Oncol Res       Date:  2010-10-31       Impact factor: 3.201

3.  Atypical amplification of chromosome region 22q12 in melanoma: A case report.

Authors:  Giuseppina Liguori; Monica Cantile; Francesca Collina; Laura Marra; Anna DE Chiara; Renato Franco; Michele Caraglia; Gerardo Botti; Mirella D'Andrea; Giovanni Francesco Nicoletti
Journal:  Oncol Lett       Date:  2015-04-27       Impact factor: 2.967

4.  Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation.

Authors:  Marcelo L Rodriguez-Puebla; Paula L Miliani de Marval; Margaret LaCava; David S Moons; Hiroaki Kiyokawa; Claudio J Conti
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

5.  [liposarcoma. Aspects of pathomorphology--an analysis of 209 tumos].

Authors:  C Kuhnen; M Lehnhardt; H U Steinau; K-M Müller
Journal:  Chirurg       Date:  2004-12       Impact factor: 0.955

6.  MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin.

Authors:  Shan Lu; Wei Zhou; Haiyun Wei; Leifeng He; Liang Li
Journal:  Dig Dis Sci       Date:  2015-08-18       Impact factor: 3.199

7.  Can HMGI-C be used as an aid with MDM2 and CDK4 to differentiate liposarcoma subtypes from their mimics?

Authors:  Hanan Alshenawy
Journal:  J Cancer Res Clin Oncol       Date:  2013-03-26       Impact factor: 4.553

Review 8.  Genomic characteristics of soft tissue sarcomas.

Authors:  Fredrik Mertens; Ioannis Panagopoulos; Nils Mandahl
Journal:  Virchows Arch       Date:  2009-02-03       Impact factor: 4.064

9.  Prognostic factors and expression of MDM2 in patients with primary extremity liposarcoma.

Authors:  Rosalvo Zósimo Bispo Júnior; Olavo Pires de Camargo; Cláudia Regina G C M de Oliveira; Renée Zon Filippi; André Mathias Baptista; Marcelo Tadeu Caiero
Journal:  Clinics (Sao Paulo)       Date:  2008-04       Impact factor: 2.365

Review 10.  Molecular pathology of sarcomas: concepts and clinical implications.

Authors:  Judith V M G Bovée; Pancras C W Hogendoorn
Journal:  Virchows Arch       Date:  2009-09-29       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.